PDL
Showing 1 - 25 of 765
PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact
Not yet recruiting
- PDL1- Colorectal Carcinoma
- (no location specified)
Jan 11, 2023
Myopia, Progressive Trial in Tianjin (Single vision lens, +2D PDL, +3D PDL)
Active, not recruiting
- Myopia, Progressive
- Single vision lens
- +3 more
-
Tianjin, ChinaTianjin Eye Hospital
May 9, 2022
Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)
Not yet recruiting
- Multiple Myeloma
- Bone marow biopsy and aspiration
- biochemical and heamatological tests
- (no location specified)
Aug 9, 2023
HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With
Not yet recruiting
- Gastric Cancer
- Observational
- (no location specified)
Dec 13, 2022
NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- MK-2870
- +2 more
- (no location specified)
Sep 15, 2023
Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT
Recruiting
- Lung Cancer Stage III
- Lung Cancer Stage IV
-
Brest, FranceChu Brest
Aug 16, 2023
Scar Trial in Chicago (PDL (Pulsed Dye Laser), Fractional Photothermolysis Laser)
Enrolling by invitation
- Scar
- PDL (Pulsed Dye Laser)
- Fractional Photothermolysis Laser
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine, Department
Mar 2, 2022
Rosacea Trial in Hamburg (532nm KTP, 585nm PDL)
Recruiting
- Rosacea
- 532nm KTP
- 585nm PDL
-
Hamburg, GermanyLaser Department, University Medical-Center Hamburg-Eppendorf
Mar 5, 2023
Sebaceous Hyperplasia Trial in Chicago (Erbium:YAG Laser, Pulsed Dye Laser, Nd:YAG Laser)
Not yet recruiting
- Sebaceous Hyperplasia
- Erbium:YAG Laser
- +3 more
-
Chicago, IllinoisNorthwestern University Department of Dermatology
Mar 2, 2022
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Acute Lymphoblastic Leukemia in Pediatric Trial in Sohag (flow cytometric immunophynotyping)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Pediatric
- flow cytometric immunophynotyping
-
Sohag, EgyptSohag University Hospital
Jun 19, 2022
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- camrelizumab for Injection
- (no location specified)
Nov 13, 2023
Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and
Not yet recruiting
- Advanced Gastroesophageal Adenocarcinoma
- +2 more
- CAPOX combined with bevacizumab and Tislelizumab
- (no location specified)
Mar 17, 2022
Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,
Not yet recruiting
- Cancer Head Neck
- +2 more
- adnectin 18F-BMS-986192 Head and Neck Cancer
- adnectin 18F-BMS-986192 Brain Metastases
-
New Haven, ConnecticutYale University PET Center
Oct 10, 2022
Port-Wine Stain Trial in Hamburg (KTP, PDL)
Recruiting
- Port-Wine Stain
- KTP
- PDL
-
Hamburg, GermanyLaser Department, University Medical Center Hamburg-Eppendorf
Mar 5, 2023
PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC
Recruiting
- Non-small Cell Lung Cancer
-
Monza, ItalyASST-Monza Ospedale San Gerardo
Jun 9, 2022
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)
Not yet recruiting
- Chemotherapy
- Radiation Therapy
- Camrelizumab
- +3 more
-
Fuzhou, ChinaFujian Medical University Union Hospital
Apr 6, 2023
Lung Cancer Trial in Assiut (Observational Study ( Tissue Biopsy ))
Completed
- Lung Cancer
- Observational Study ( Tissue Biopsy )
-
Assiut, EgyptAssiut University
Oct 18, 2021
Rosacea Trial in Chicago (Pulse Dye Laser/YAG laser)
Completed
- Rosacea
- Pulse Dye Laser/YAG laser
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine, Department
Nov 30, 2021
Cancer Trial in Besancon (Biological samples, Anti PD1/PDL1 treatment)
Recruiting
- Cancer
- Biological samples
- Anti PD1/PDL1 treatment
-
Besancon, FranceUniversity Hospital of Besançon
Jul 30, 2021